Management of nonvalvular atrial fibrillation: A comprehensive approach

Indian Journal of Medical Sciences

Volumn 63, Issue 9, 2009, Pages 419-430

  Iuliano, Luigi ^a   Di Matteo, Antonio ^a   Straface, Giuseppe ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Aspirin; Atrial fibrillation; Stroke; Thromboembolism; Thrombosis; Warfarin

Indexed keywords

ACETYLSALICYLIC ACID; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIGOXIN; ESMOLOL; HEPARIN; METOPROLOL; PLACEBO; PROPRANOLOL; VERAPAMIL; WARFARIN;

ADD ON THERAPY; BLEEDING; BRAIN HEMORRHAGE; CARDIOVASCULAR RISK; CARDIOVERSION; CEREBROVASCULAR ACCIDENT; CLINICAL PRACTICE; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG EFFICACY; GASTROINTESTINAL HEMORRHAGE; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART ELECTROPHYSIOLOGY; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HEART RATE; HEART RHYTHM; HUMAN; HYPERTENSION; INCIDENCE; MITRAL VALVE DISEASE; MORBIDITY; MORTALITY; MYOCARDITIS; OPEN HEART SURGERY; OUTCOME ASSESSMENT; PERICARDITIS; REVIEW; RISK REDUCTION; RR INTERVAL; STROKE; THROMBOEMBOLISM; THROMBOSIS; TRANSIENT ISCHEMIC ATTACK; UNSPECIFIED SIDE EFFECT;

ANTI-ARRHYTHMIA AGENTS; ANTICOAGULANTS; ASPIRIN; ATRIAL FIBRILLATION; FIBRINOLYTIC AGENTS; HUMANS; PLATELET AGGREGATION INHIBITORS; RISK FACTORS; STROKE; THROMBOEMBOLISM; WARFARIN;

EID: 70349817071     PISSN: 00195359     EISSN: 19983654     Source Type: Journal    
DOI: 10.4103/0019-5359.56111     Document Type: Review

References (61)

1. Lake Fr, Cullen Kj, De Klerk Nh, Mccall Mg, Rosman Dl. Atrial Fibrillation And Mortality In An Elderly Population. Aust N Z J Med 1989;19: 321-326
2. Wolf Pa, Abbott Rd, Kannel Wb. Atrial Fibrillation As An Independent Risk Factor For Stroke: The Framingham Study. Stroke 1991;22:983-988
3. Iuliano L, Micheletta F. Atrial Fibrillation: Epidemiology And Physiopathology. Haematologica 2001;86:1-4.
4. Gallagher Mm, Camm J. Classification Of Atrial Fibrillation. Am J Cardiol 1998;82:18n-28n. (Pubitemid 28507116)
5. Levy S. Classification System Of Atrial Fibrillation. Curr Opin Cardiol 2000;15:54-57
6. Fuster V, Ryden Le, Cannom Ds, Crijns Hj, Curtis Ab, Ellenbogen Ka, et al. Acc/Aha/Esc 2006 Guidelines For The Management Of Patients With Atrial Fibrillation: A Report Of The American College Of Cardiology/American Heart Association Task Force On Practice Guidelines And The European Society Of Cardiology Committee For Practice Guidelines (Writing Committee To Revise The 2001 Guidelines For The Management Of Patients With Atrial Fibrillation): Developed In Collaboration With The European Heart Rhythm Association And The Heart Rhythm Society. Circulation 2006;114:E257-354.
7. Singer De, Albers Gw, Dalen Je, Fang Mc, Go As, Halperin Jl, et al. Antithrombotic Therapy In Atrial Fibrillation: American College Of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008;133:546s-92s.
8. Hodgson-Zingman Dm, Karst Ml, Zingman Lv, Heublein Dm, Darbar D, Herron Kj, et al. Atrial Natriuretic Peptide Frameshift Mutation In Familial Atrial Fibrillation. N Engl J Med 2008;359:158-165
9. Fuster V, Ryden Le, Cannom Ds, Crijns Hj, Curtis Ab, Ellenbogen Ka, et al Acc/Aha/Esc 2006 Guidelines For The Management Of Patients With Atrial Fibrillation: Full Text: A Report Of The American College Of Cardiology/American Heart Association Task Force On Practice Guidelines And The European Society Of Cardiology Committee For Practice Guidelines (Writing Committee To Revise The 2001 Guidelines For The Management Of Patients With Atrial Fibrillation) Developed In Collaboration With The European Heart Rhythm Association And The Heart Rhythm Society. Europace 2006;8:651-745.
10. Andrews Tc, Reimold Sc, Berlin Ja, Antman Em. Prevention Of Supraventricular Arrhythmias After Coronary Artery Bypass Surgery: A Meta- Analysis Of Randomized Control Trials. Circulation 1991;84:Iii236-44.
11. Mathew Jp, Fontes Ml, Tudor Ic, Ramsay J, Duke P, Mazer Cd, et al. A Multicenter Risk Index For Atrial Fibrillation After Cardiac Surgery. Jama 2004;291:1720-1729
12. Umana E, Solares Ca, Alpert Ma. Tachycardia- Induced Cardiomyopathy. Am J Med 2003;114: 51-55
13. Van Gelder Ic, Hagens Ve, Bosker Ha, Kingma Jh, Kamp O, Kingma T, et al. A Comparison Of Rate Control And Rhythm Control In Patients With Recurrent Persistent Atrial Fibrillation. N Engl J Med 2002;347:1834-1840
14. Wyse Dg, Waldo Al, Dimarco Jp, Domanski Mj, Rosenberg Y, Schron Eb, et al. A Comparison Of Rate Control And Rhythm Control In Patients With Atrial Fibrillation. N Engl J Med 2002;347: 1825-1833
15. Gronefeld Gc, Lilienthal J, Kuck Kh, Hohnloser Sh. Impact Of Rate Versus Rhythm Control On Quality Of Life In Patients With Persistent Atrial Fibrillation: Results From A Prospective Randomized Study. Eur Heart J 2003;24:1430-1436
16. Opolski G, Torbicki A, Kosior Da, Szulc M, Wozakowska-Kaplon B, Kolodziej P, et al. Rate Control Vs Rhythm Control In Patients With Nonvalvular Persistent Atrial Fibrillation: The Results Of The Polish How To Treat Chronic Atria Fibrillation (Hot Cafe) Study. Chest 2004;126: 476-486
17. Jenkins Ls, Brodsky M, Schron E, Chung M, Rocco T Jr, Lader E, et al. Quality Of Life In Atrial Fibrillation: The Atrial Fibrillation Follow-Up Investigation Of Rhythm Management (Affirm) Study. Am Heart J 2005;149:112-120
18. Hohnloser Sh, Kuck Kh, Lilienthal J. Rhythm Or Rate Control In Atrial Fibrillation--Pharmacologica Intervention In Atrial Fibrillation (Piaf): A Randomised Trial. Lancet 2000;356:1789-1794
19. Zipes Dp, Camm Aj, Borggrefe M, Buxton Ae, Chaitman B, Fromer M, et al. Acc/Aha/Esc 2006 Guidelines For Management Of Patients With Ventricular Arrhythmias And The Prevention Of Sudden Cardiac Death: A Report Of The American College Of Cardiology/American Heart Association Task Force And The European Society Of Cardiology Committee For Practice Guidelines (Writing Committee To Develop Guidelines For Management Of Patients With Ventricular Arrhythmias And The Prevention Of Sudden Cardiac Death) Developed In Collaboration With The European Heart Rhythm Association And The Heart Rhythm Society. Europace 2006;8:746-837.
20. Wood Ma, Brown-Mahoney C, Kay Gn, Ellenbogen Ka. Clinical Outcomes After Ablation And Pacing Therapy For Atrial Fibrillation: A Meta-Analysis. Circulation 2000;101:1138-1144
21. Falk Rh, Knowlton Aa, Bernard Sa, Gotlieb Ne, Battinelli Nj. Digoxin For Converting Recent- Onset Atrial Fibrillation To Sinus Rhythm: A Randomized, Double-Blinded Trial. Ann Intern Med 1987;106:503-506
22. Intravenous Digoxin In Acute Atrial Fibrillation. Results Of A Randomized, Placebo-Controlled Multicentre Trial In 239 Patients: The Digitalis In Acute Atrial Fibrillation (Daaf) Trial Group. Eur Heart J 1997;18:649-654
23. Naccarelli Gv, Wolbrette Dl, Luck Jc. Proarrhythmia. Med Clin North Am 2001;85:503-26, Xii.
24. De Paola Aa, Figueiredo E, Sesso R, Veloso Hh, Nascimento Lo. Effectiveness And Costs Of Chemical Versus Electrical Cardioversion Of Atrial Fibrillation. Int J Cardiol 2003;88:157-166
25. Asher Cr, Klein Al. Transesophageal Echocardiography To Guide Cardioversion In Patients With Atrial Fibrillation: Acute Trial Update. Card Electrophysiol Rev 2003;7:387-391
26. Seidl K, Rameken M, Drogemuller A, Vater M, Brandt A, Schwacke H, et al. Embolic Events In Patients With Atrial Fibrillation And Effective Anticoagulation: Value Of Transesophageal Echocardiography To Guide Direct-Current Cardioversion: Final Results Of The Ludwigshafen Observational Cardioversion Study. J Am Coll Cardiol 2002;39:1436-1442
27. Lip Gy. Cardioversion Of Atrial Fibrillation: From Guidelines To Contemporary Clinical Practice. Int J Clin Pract 2007;61:714-716
28. Cox Jl, Schuessler Rb, Lappas Dg, Boineau Jp. An 8 1/2-Year Clinical Experience With Surgery For Atrial Fibrillation. Ann Surg 1996;224:267-73; Discussion 73-75
29. Haissaguerre M, Jais P, Shah Dc, Takahashi A, Hocini M, Quiniou G, et al. Spontaneous Initiation Of Atrial Fibrillation By Ectopic Beats Originating In The Pulmonary Veins. N Engl J Med 1998;339:659-666
30. Capucci A, Villani Gq, Aschieri D, Rosi A, Piepoli Mf. Oral Amiodarone Increases The Efficacy Of Direct-Current Cardioversion In Restoration Of Sinus Rhythm In Patients With Chronic Atrial Fibrillation. Eur Heart J 2000;21:66-73.
31. Damiano Rj Jr, Gaynor Sl, Bailey M, Prasad S, Cox Jl, Boineau Jp, et al. The Long-Term Outcome Of Patients With Coronary Disease And Atrial Fibrillation Undergoing The Cox Maze Procedure. J Thorac Cardiovasc Surg 2003;126:2016-2021 (Pubitemid 38020767)
32. Go As, Hylek Em, Phillips Ka, Borowsky Lh, Henault Le, Chang Y, et al. Implications Of Stroke Risk Criteria On The Anticoagulation Decision In Nonvalvular Atrial Fibrillation: The Anticoagulation And Risk Factors In Atrial Fibrillation (Atria) Study. Circulation 2000;102:11-13
33. Pearce La, Hart Rg, Halperin Jl. Assessment Of Three Schemes For Stratifying Stroke Risk In Patients With Nonvalvular Atrial Fibrillation. Am J Med 2000;109:45-51.
34. Singer De, Albers Gw, Dalen Je, Go As, Halperin Jl, Manning Wj. Antithrombotic Therapy In Atrial Fibrillation: The Seventh Accp Conference On Antithrombotic And Thrombolytic Therapy. Chest 2004;126:429s-56s.
35. Gage Bf, Van Walraven C, Pearce L, Hart Rg, Koudstaal Pj, Boode Bs, et al. Selecting Patients With Atrial Fibrillation For Anticoagulation: Stroke Risk Stratification In Patients Taking Aspirin. Circulation 2004;110:2287-2292
36. Hart Rg, Pearce La, Aguilar Mi. Meta-Analysis: Antithrombotic Therapy To Prevent Stroke In Patients Who Have Nonvalvular Atrial Fibrillation. Ann Intern Med 2007;146:857-867
37. Risk Factors For Stroke And Efficacy Of Antithrombotic Therapy In Atrial Fibrillation. Analysis Of Pooled Data From Five Randomized Controlled Trials. Arch Intern Med 1994;154:1449-1457
38. Hart Rg, Pearce La, Mcbride R, Rothbart Rm, Asinger Rw. Factors Associated With Ischemic Stroke During Aspirin Therapy In Atrial Fibrillation: Analysis Of 2012 Participants In The Spaf I-Iii Clinical Trials: The Stroke Prevention In Atrial Fibrillation (Spaf) Investigators. Stroke 1999;30:1223-1229
39. Gage Bf, Waterman Ad, Shannon W, Boechler M, Rich Mw, Radford Mj. Validation Of Clinical Classification Schemes For Predicting Stroke: Results From The National Registry Of Atrial Fibrillation. Jama 2001;285:2864-2870
40. Wang Tj, Massaro Jm, Levy D, Vasan Rs, Wolf Pa, Dagostino Rb, et al. A Risk Score For Predicting Stroke Or Death In Individuals With New-Onset Atrial Fibrillation In The Community: The Framingham Heart Study. Jama 2003;290: 1049-1056
41. Hughes M, Lip Gy. Stroke And Thromboembolism In Atrial Fibrillation: A Systematic Review Of Stroke Risk Factors, Risk Stratification Schema And Cost Effectiveness Data. Thromb Haemost 2008;99:295-304.
42. Laupacis A, Albers G, Dalen J, Dunn Mi, Jacobson Ak, Singer De. Antithrombotic Therapy In Atrial Fibrillation. Chest 1998;114:579s-89s.
43. Predictors Of Thromboembolism In Atrial Fibrillation: Ii: Echocardiographic Features Of Patients At Risk: The Stroke Prevention In Atrial Fibrillation Investigators. Ann Intern Med 1992;116:6-12.
44. Jones Ef, Calafiore P, Mcneil Jj, Tonkin Am, Donnan Ga. Atrial Fibrillation With Left Atrial Spontaneous Contrast Detected By Transesophageal Echocardiography Is A Potent Risk Factor For Stroke. Am J Cardiol 1996;78: 425-429
45. Hylek Em, Skates Sj, Sheehan Ma, Singer De. An Analysis Of The Lowest Effective Intensity Of Prophylactic Anticoagulation For Patients With Nonrheumatic Atrial Fibrillation. N Engl J Med 1996;335:540-546
46. Fang Mc, Go As, Chang Y, Borowsky L, Pomernacki Nk, Singer De. Comparison Of Risk Stratification Schemes To Predict Thromboembolism In People With Nonvalvular Atrial Fibrillation. J Am Coll Cardiol 2008;51:810-815
47. Ezekowitz Md, Bridgers Sl, James Ke, Carliner Nh, Colling Cl, Gornick Cc, et al. Warfarin In The Prevention Of Stroke Associated With Nonrheumatic Atrial Fibrillation: Veterans Affairs Stroke Prevention In Nonrheumatic Atrial Fibrillation Investigators. N Engl J Med 1992;327:1406-1412
48. Petersen P, Boysen G, Godtfredsen J, Andersen Ed, Andersen B. Placebo-Controlled, Randomised Trial Of Warfarin And Aspirin For Prevention Of Thromboembolic Complications In Chronic Atrial Fibrillation: The Copenhagen Afasak Study. Lancet 1989;1:175-179
49. Subramaniam B, Riley Mf, Panzica Pj, Manning Wj. Transesophageal Echocardiographic Assessment Of Right Atrial Appendage Anatomy And Function: Comparison With The Left Atrial Appendage And Implications For Local Thrombus Formation. J Am Soc Echocardiogr 2006;19:429-433
50. Cast: Randomised Placebo-Controlled Trial Of Early Aspirin Use In 20,000 Patients With Acute Ischaemic Stroke: Cast (Chinese Acute Stroke Trial) Collaborative Group. Lancet 1997;349:1641-1649
51. Collaborative Overview Of Randomised Trials Of Antiplatelet Therapy--I: Prevention Of Death, Myocardial Infarction, And Stroke By Prolonged Antiplatelet Therapy In Various Categories Of Patients: Antiplatelet Trialists. Collaboration. Bmj 1994;308:81-106.
52. Adjusted-Dose Warfarin Versus Low-Intensity, Fixed-Dose Warfarin Plus Aspirin For High-Risk Patients With Atrial Fibrillation: Stroke Prevention In Atrial Fibrillation Iii Randomised Clinical Trial. Lancet 1996;348:633-638
53. Gullov Al, Koefoed Bg, Petersen P, Pedersen Ts, Andersen Ed, Godtfredsen J, et al. Fixed Minidose Warfarin And Aspirin Alone And In Combination Vs Adjusted-Dose Warfarin For Stroke Prevention In Atrial Fibrillation: Second Copenhagen Atrial Fibrillation, Aspirin, And Anticoagulation Study. Arch Intern Med 1998;158:1513-1521
54. Connolly S, Pogue J, Hart R, Pfeffer M, Hohnloser S, Chrolavicius S, et al. Clopidogrel Plus Aspirin Versus Oral Anticoagulation For Atrial Fibrillation In The Atrial Fibrillation Clopidogrel Trial With Irbesartan For Prevention Of Vascular Events (Active W): A Randomised Controlled Trial. Lancet 2006;367:1903-1912
55. Healey Js, Hart Rg, Pogue J, Pfeffer Ma, Hohnloser Sh, De Caterina R, et al. Risks And Benefits Of Oral Anticoagulation Compared With Clopidogrel Plus Aspirin In Patients With Atrial Fibrillation According To Stroke Risk: The Atrial Fibrillation Clopidogrel Trial With Irbesartan For Prevention Of Vascular Events (Active-W). Stroke 2008;39:1482-1486
56. Connolly Sj, Pogue J, Hart Rg, Hohnloser Sh, Pfeffer M, Chrolavicius S, et al. Effect Of Clopidogrel Added To Aspirin In Patients With Atrial Fibrillation. N Engl J Med 2009;360:2066-2078
57. Mant J, Hobbs Fd, Fletcher K, Roalfe A, Fitzmaurice D, Lip Gy, et al. Warfarin Versus Aspirin For Stroke Prevention In An Elderly Community Population With Atrial Fibrillation (The Birmingham Atrial Fibrillation Treatment Of The Aged Study, Bafta): A Randomised Controlled Trial. Lancet 2007;370:493-503. (Pubitemid 47212371)
58. Olshansky B, Rosenfeld Le, Warner Al, Solomon Aj, O.neill G, Sharma A, et al. The Atrial Fibrillation Follow-Up Investigation Of Rhythm Management (Affirm) Study: Approaches To Control Rate In Atrial Fibrillation. J Am Coll Cardiol 2004;43: 1201-1208 (Pubitemid 38452597)
59. Secondary Prevention In Non-Rheumatic Atrial Fibrillation After Transient Ischaemic Attack Or Minor Stroke: Eaft (European Atrial Fibrillation Trial) Study Group. Lancet 1993;342:1255-1262
60. Rathore Ss, Berger Ak, Weinfurt Kp, Schulman Ka, Oetgen Wj, Gersh Bj, et al. Acute Myocardial Infarction Complicated By Atrial Fibrillation In The Elderly: Prevalence And Outcomes. Circulation 2000;101:969-974
61. Patrono C, Baigent C, Hirsh J, Roth G. Antiplatelet Drugs: American College Of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008;133:199s-233s.